文献速递神经肿瘤

复发性库欣病:不同治疗方式利弊的全面综述

Recurrent Cushing Disease: An Extensive Review on Pros and Cons of Different Therapeutic Approaches.
PubMed 文献 · World Neurosurg · 2023-02-03

本系统综述与Meta分析纳入61篇文章、723例复发性库欣病患者,比较经蝶手术、放疗和药物治疗后的缓解率与并发症。经蝶手术、放疗和药物治疗的缓解率分别为0.65、0.57和0.75,亚组间差异有统计学意义(P=0.01),事后检验显示经蝶手术(P=0.0344)和药物治疗(P=0.0149)缓解率高于放疗;并发症如尿崩症(P=1.0)和垂体功能减退(P=0.28)在不同治疗方式间无统计学显著差异。

要点

  • 复发性库欣病经蝶手术、放疗和药物治疗的缓解率分别为0.65、0.57和0.75。
  • 亚组间缓解率差异有统计学意义(P=0.01),经蝶手术和药物治疗均高于放疗。
  • 尿崩症(P=1.0)和垂体功能减退(P=0.28)在不同治疗方式间无统计学显著差异。

核心结论

  • 与药物治疗和经蝶手术相比,放疗的缓解率在统计学上更低。
  • 尽管手术优于放疗的证据充分,但药物治疗数据的解读须谨慎,因纳入病例数少且置信区间宽。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE(通过PubMed)和Cochrane电子文献数据库至2020年。
  • 纳入61篇描述复发性库欣病患者治疗管理并报告代表性结局的文章,共723例患者接受不同治疗方式。

主要发现

  • 经蝶手术、放疗和药物治疗亚组的缓解率分别为0.65(95%CI 0.60-0.70)、0.57(95%CI 0.51-0.63)和0.75(95%CI 0.60-0.86)。
  • 复发性库欣病患者治疗后的总缓解率为0.64(95%CI 0.60-0.68)。
  • 亚组差异检验显示不同亚组间差异有统计学意义(P=0.01);事后检验显示经蝶手术(P=0.0344)和药物治疗(P=0.0149)缓解率高于放疗。
  • 不同治疗方式在并发症方面无统计学显著差异,包括尿崩症(P=1.0)和垂体功能减退(P=0.28)。

局限性

  • 药物治疗数据的解读须谨慎,因纳入病例数少且置信区间宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recurrent Cushing disease (CD) is characterized by the reappearance of clinical and hormonal aspects of hypercortisolism that occur more than 6 months after an initial post-treatment remission. METHODS: We performed a systematic review and meta-analysis to synthesize the evidence about remission and complication rates after transsphenoidal surgery (TSS) radiotherapy (RT) and medical therapy (MT) in recurrent CD patients. A quantitative systematic review was performed. Article selection was performed by searching MEDLINE (using PubMed), and Cochrane electronic bibliographic databases through 2020. RESULTS: We noted 61 articles described therapeutic management of recurrent CD patients with representative outcome. A total of 723 patients received different therapeutic modality for their recurrent CD. The remission rates were 0.65 (95% confidence interval [CI] 0.60-0.70), 0.57 (95% CI 0.51-0.63), and 0.75 (95% CI 0.60-0.86) in the TSS, RT, and MT subgroups, respectively. The total remission rate after therapeutic approaches on recurrent CD patients was 0.64 (95% CI 0.60-0.68). A test for subgroup differences revealed there was a statistically significant difference between different subgroups (P = 0.01). The post hoc test showed that in comparison with RT, TSS (P = 0.0344) and MT (P = 0.0149) had a higher rate of remission. However, there was no statistically significant difference between separate therapeutic modalities in terms of complications including diabetes insipidus (P = 1.0) and hypopituitarism (P = 0.28). CONCLUSIONS: Compared MT and TSS, RT has a statistically lower rate of remission. Although there is robust superiority of surgery over RT, interpretation of MT data must considered with caution due to the small number of included cases and wide CI range.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sabahi M, Ghasemi-Nesari P, Maroufi SF, et al. Recurrent Cushing Disease: An Extensive Review on Pros and Cons of Different Therapeutic Approaches. World Neurosurg. 2023. PMID: 36739900. doi:10.1016/j.wneu.2023.01.108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。